[Inhibins and Activin A in hypertensive Disorders of Pregnancy and HELLP-Syndrome]

Zentralbl Gynakol. 2004 Jun;126(3):148-53. doi: 10.1055/s-2004-822592.
[Article in German]

Abstract

Objective: Are serum concentrations of the ovarian glycoproteins inhibin A, inhibin B, pro-alpha-C and activin A different in normotensive, chronical hypertensive or pregancies complicated by preeclampsia or HELLP-syndrome? What are the clinical consequences?

Methods: Serum concentrations of inhibin A, inhibin B, pro-alpha-C, and activin A of 99 women (37 normotensive patients, 23 patients with chronical hypertension, 25 women with preeclampsia and 14 patients with HELLP-syndrome) at different stages of pregnancy were determined by high specific ELISAS.

Results: During pregnancy serum levels of all parameters increased continually and fell rapidly within parturition. Activin A and inhibin B levels showed significant higher serum concentrations in patients with preeclampsia and - even more pronounced - in patients with HELLP-syndrome. Normotensive and chronically hypertensive patients were not different.

Conclusion: Activin A and inhibin A appear to be viable candidates as laboratory parameters for detection of pregnancy induced hypertension. Maybe furthermore both parameters will allow the discrimination between chronic hypertension and hypertension induced by pregnancy.

Publication types

  • English Abstract

MeSH terms

  • Activins / therapeutic use*
  • Female
  • HELLP Syndrome / drug therapy*
  • Humans
  • Hypertension / drug therapy
  • Inhibin-beta Subunits / therapeutic use*
  • Inhibins / therapeutic use*
  • Pre-Eclampsia / drug therapy
  • Pregnancy
  • Pregnancy Complications / drug therapy*
  • Pregnancy Complications, Cardiovascular / drug therapy

Substances

  • activin A
  • inhibin B
  • Activins
  • Inhibins
  • Inhibin-beta Subunits